Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases

Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds

(2013) E. Bilsland et al.   Open Biology

Automated design of ligands to polypharmacological profiles

(2012) Jérémy Besnard et al.   NATURE

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target

(2012) Y. Yuthavong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drugs for Neglected Diseasesinitiativemodel of drug development for neglected diseases: current status and future challenges

(2011) Jean-Robert Ioset et al.   Future Medicinal Chemistry

The productivity crisis in pharmaceutical R&D

(2011) Fabio Pammolli et al.   NATURE REVIEWS DRUG DISCOVERY

Drug Developers Finally Take Aim at a Neglected Disease

(2011) M. Leslie   SCIENCE

Synthesis of a Drug-Like Focused Library of Trisubstituted Pyrrolidines Using Integrated Flow Chemistry and Batch Methods

(2011) Marcus Baumann et al.   ACS Combinatorial Science

Open Babel: An open chemical toolbox

(2011) Noel M O'Boyle et al.   Journal of Cheminformatics

Virtual screening: an endless staircase?

(2010) Gisbert Schneider   NATURE REVIEWS DRUG DISCOVERY

A survey of yeast genomic assays for drug and target discovery

(2010) Andrew M. Smith et al.   PHARMACOLOGY & THERAPEUTICS

Antiparasitic activities of novel, orally available fumagillin analogs

(2009) Christopher Arico-Muendel et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Fumagillin and Fumarranol Interact with P. falciparum Methionine Aminopeptidase 2 and Inhibit Malaria Parasite Growth In Vitro and In Vivo

(2009) Xiaochun Chen et al.   CHEMISTRY & BIOLOGY

The Automation of Science

(2009) Ross D. King et al.   SCIENCE